A series of 2-phenyl- or 3-phenyl piperazines, structurally related to DM235 and DM232, two potent nootropic agents, have been prepared and tested in the mouse passive-avoidance test, to assess their ability to revert scopolamine-induced amnesia. Although the newly synthesized molecules were less potent than the parent compounds, some useful information has been obtained from structure-activity relationships. A small but significant enantioselectivity has been found for the most potent compound 5a.
Keywords: Cognition-enhancers; Mouse passive-avoidance test; Piperazines; Piracetam-like compounds; Sunifiram.
Copyright © 2015 Elsevier Ltd. All rights reserved.